Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Kono, Toru ^a   Mamiya, Noriaki ^a,b   Chisato, Naoyuki ^a   Ebisawa, Yosiaki ^a   Yamazaki, Hirotaka ^c   Watari, Jiro ^c   Yamamoto, Yasuhiro ^d   Suzuki, Shigetaka ^d   Asama, Toshiyuki ^a   Kamiya, Kazunori ^e  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Higashiasahikawa Hospital   (Japan)

^c Kushiro Animal Hospital   (Japan)

^d Kobayashi Hospital   (Japan)

^e Karasawa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GLUCONATE CALCIUM; GOSHAJINKIGAN; HERBACEOUS AGENT; MAGNESIUM SULFATE; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

EID: 79952239072     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep200     Document Type: Article

References (26)

1. Engstrom P. F., Benson A. B. III, Chen Y.-J., Choti M. A., Dilawari R. A., Enke C. A., Fakih M. G., Fuchs C., Kiel K., Knol J. A., Leong L. A., Ludwig K. A., Martin E. W. Jr., Rao S., Saif M. W., Saltz L., Skibber J. M., Venook A. P., Yeatman T. J., NCCN clinical practice guidelines in oncology: colon cancer Journal of the National Comprehensive Cancer Network 2009 7 778 831
2. Engstrom P. F., Benson A. B. III, Chen Y.-J., Choti M. A., Dilawari R. A., Enke C. A., Fakih M. G., Fuchs C., Kiel K., Knol J. A., Leong L. A., Ludwig K. A., Martin E. W. Jr., Rao S., Saif M. W., Saltz L., Skibber J. M., Venook A. P., Yeatman T. J., NCCN clinical practice guidelines in oncology: colon cancer Journal of the National Comprehensive Cancer Network 2009 7 738 881
3. Zuckerman D. S., Clark J. W., Systemi (Pubitemid 351574063)
4. Cassidy J., Misset J.-L., Oxaliplatin-related side effects: characteristics and management Seminars in Oncology 2002 29 5 11 20 (Pubitemid 35191037)
5. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., De Braud F., Wilson C., Morvan F., Bonetti A., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer Journal of Clinical Oncology 2000 18 16 2938 2947 (Pubitemid 30644117)
6. Gamelin L., Boisdron-Celle M., Delva R., Guerin-Meyer V., Ifrah N., Morel A., Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer Clinical Cancer Research 2004 10 4055 4061 (Pubitemid 38812481)
7. Gamelin E., Gamelin L., Bossi L., Quasthoff S., Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures Seminars in Oncology 2002 29 5 21 33 (Pubitemid 35191038)
8. von Delius S., Eckel F., Wagenpfeil S., Mayr M., Stock K., Kullmann F., Obermeier F., Erdmann J., Schmelz R., Quasthoff S., Adelsberger H., Bredenkamp R., Schmid R. M., Lersch C., Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study Investigational New Drugs 2007 25 2 173 180 (Pubitemid 46020877)
9. Wilson R. H., Lehky T., Thomas R. R., Quinn M. G., Floeter M. K., Grem J. L., Acute oxaliplatin-induced peripheral nerve hyperexcitability Journal of Clinical Oncology 2002 20 7 1767 1774 (Pubitemid 34273265)
10. Lersch C., Schmelz R., Eckel F., Erdmann J., Mayr M., Schulte-Frohlinde E., Quasthoff S., Grosskreutz J., Adelsberger H., Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer Clinical Colorectal Cancer 2002 2 1 54 58 (Pubitemid 34704965)
11. Cascinu S., Catalano V., Cordella L., Labianca R., Giordani P., Baldelli A. M., Beretta G. D., Ubiali E., Catalano G., Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial Journal of Clinical Oncology 2002 20 16 3478 3483
12. Uno T., Ohsawa I., Tokudome M., Sato Y., Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes Diabetes Research and Clinical Practice 2005 69 2 129 135 (Pubitemid 40943477)
13. Tawata M., Kurihara A., Nitta K., Iwase E., Gan N., Onaya T., The effects of Goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy Diabetes Research and Clinical Practice 1994 26 2 121 128
14. Usuki Y., Usuki S., Hommura S., Successful treatment of a senile diabetic woman with cataract with goshajinkigan American Journal of Chinese Medicine 1991 19 3-4 259 263
15. Sato Y., Sakamoto N., Treatment of Diabetic Neuropathy with Niu-Che-Sen-Qi-Wan. Recent Advances in Traditional Medicine in East Asia 1985 Amsterdam, The Netherlands Excerpta Medica
16. Mamiya N., Kono T., Mamiya K., Satomi M., Chisato N., Ebisawa Y., A case of neurotoxicity reduced with goshajinkigan in modified FOLFOX6 chemotherapy for advanced colon cancer Gan to Kagaku Ryoho 2007 34 8 1295 1297
17. Shindo Y., Tenma K., Imano H., Hibino M., Yoshino K., Nakamura M., Reduction of oxaliplatin-related neurotoxicity by Gosha-jinki-gan Gan to Kagaku Ryoho 2008 35 5 863 865
18. Shirao K., Matsumura Y., Yamada Y., Muro K., Gotoh M., Boku N., Ohtsu A., Nagashima F., Sano Y., Mutoh M., Tanigawara Y., Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors Japanese Journal of Clinical Oncology 2006 36 5 295 300 (Pubitemid 43997334)
19. Therasse P., Arbuck S. G., Eisenhauer E. A., Wanders J., Kaplan R. S., Rubinstein L., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Journal of the National Cancer Institute 2000 92 205 216
20. Cersosimo R. J., Oxaliplatin-associated neuropathy: a review Annals of Pharmacotherapy 2005 39 1 128 135 (Pubitemid 40052388)
21. Fujiwara K., Imanishi J., Watanabe S., Ozasa K., Sakurada K., Changes in attitudes of Japanese doctors toward complementary and alternative medicine-comparison of surveys in 1999 and 2005 in Kyoto. Evidence-Based Complementary and Alternative Medicine. In press
22. Choi S. H., Chang I. M., A milestone in codifying the wisdom of traditional oriental medicine: TCM, Kampo, TKM, TVM-WHO International Standard terminologies on traditional medicine in the Western Pacific region Evidence-Based Complementary and Alternative Medicine 2010 7 3 303 305
23. Yamada K., Suzuki E., Nakaki T., Watanabe S., Kanba S., Aconiti tuber increases plasma nitrite and nitrate levels in humans Journal of Ethnopharmacology 2005 96 1-2 165 169 (Pubitemid 39575047)
24. Gotoh A., Goto K., Sengoku A., Shirakawa T., Akao Y., Fujisawa M., Okada H., Arakawa S., Kamidono S., Inhibition mechanism of Gosha-jinki-gan on the micturition reflex in rats Journal of Pharmacological Sciences 2004 96 2 115 123 (Pubitemid 39469602)
25. Hu X., Sato J., Oshida Y., Xu M., Bajotto G., Sato Y., Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats Diabetes Research and Clinical Practice 2003 59 2 103 111 (Pubitemid 36135828)
26. Kono T., Mishima H., Shimada M., Morita S., Sakamoto J., Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study) Japanese Journal of Clinical Oncology 2009 39 12 847 84